SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-21-000004
Filing Date
2021-01-28
Accepted
2021-01-28 08:11:44
Documents
4
Period of Report
2021-01-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kx12821.htm 8-K 24016
2 EX-99.1 ex991-12821.htm EX-99.1 20048
3 phasebio2020logo1.jpg GRAPHIC 27705
4 reverseitlogo1.jpg GRAPHIC 45254
  Complete submission text file 0001169245-21-000004.txt   146095
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 21562085
SIC: 2834 Pharmaceutical Preparations